Despite the strong and consistent evidence supporting that a high physical fitness (PF) level at any age is a major predictor of a healthier metabolic profile, major studies focused on the metabolically healthy but obese (MHO) phenotype have ignored the role of PF when examining this phenotype and its prognosis. Particularly, the role of its main health-related components such as higher cardiorespiratory fitness (CRF) and muscular fitness in the MHO phenotype need to be reviewed in depth. The present review aimed to: 1) contribute to the characterization of the MHO phenotype by examining whether MHO individuals are fitter than metabolically abnormal obese (MAO) individuals in terms of CRF and other PF components; 2) review the role of CRF and other PF components in the prognosis of MHO. The studies reviewed suggest that a higher CRF level should be considered a characteristic of the MHO phenotype.
Introduction
Strong and consistent evidence supports that a higher cardiorespiratory fitness (CRF) level at any age is a major predictor of a healthier metabolic profile, as well as a lower risk for incident cardiovascular disease (CVD) and CVD mortality [1] [2] [3] [4] . Based on this evidence, it would be expected that epidemiological studies and reviews focusing on metabolic syndrome and/or CVD would account for CRF in their analyses or if CRF data are not available, would at least mention it as a limitation. The same would apply when studying the metabolically healthy but obese (MHO) phenotype, a condition in which obesity coexists with a fully healthy metabolic profile. MHO is present in 10-30% of obese adults 5 and in 6-36% of obese children/adolescents 6, 7 , with prevalence differences largely due to different definitions of MHO. Unfortunately, many of the major studies on this topic ignored the critical impact of CRF. As an example, Primeau et al. 8 reviewed the existing literature and reported a number of characteristics of the MHO phenotype, including lower visceral fat accumulation, higher birth weight, adipose cell size, and gene expression-encoding markers of adipose cell differentiation;
however, CRF was not mentioned. Likewise, Kramer et al. 9 conducted a systematic review and meta-analysis about the prognosis of individuals who are MHO, but again, the potential role of CRF in this prognosis was ignored. Another recent high profile study by Bell and colleagues indicated that a high percentage of those with MHO usually lose their metabolic health over time, much more so than do leaner subjects who are also metabolically healthy 10 ; however, we have argued that this analysis also did not assess physical activity much less CRF 11 . On the other hand, the latest literature on this topic does acknowledge that CRF levels should be considered and that CRF could play a central role in the risk of mortality in MHO individuals [12] [13] [14] . Moreover, a recent review specifically explored the role of CRF when comparing healthy obese with
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5 unhealthy lean, and concluded that greater emphasis should be placed on improving CRF rather than weight loss per se in the primary and secondary prevention of CVD, at least in patients with overweight and class I obesity (body mass index, BMI 25-35 kg/m 2 ) 15 .
Although available information is promising, whether a higher CRF is a characteristic in MHO individuals has not been specifically reviewed. In order to address this question we searched for studies assessing both CRF and the MHO phenotype in adults as well as in youth up to March 31 st 2015. We decided to extend the search to other healthrelated physical fitness (PF) components, such as muscular strength (MS), flexibility and balance. Particularly, there is accumulating evidence supporting that MS is an emerging predictor for CVD mortality, independently of traditional risk factors such as obesity and hypertension, and also independently of CRF [16] [17] [18] [19] ; however, its role in the MHO phenotype is unknown. Likewise, there is a need for an update on the potential role of PF on the prognosis of MHO individuals. The present review specifically aimed to: 1) contribute to the characterization of the MHO phenotype by examining whether MHO individuals are fitter than metabolically abnormal obese (MAO) individuals in terms of CRF and other PF components; 2) review the role of CRF and other PF components in the prognosis of MHO.
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Are MHO individuals fitter than their MAO peers? Current evidence from crosssectional data
Overall description of the studies reviewed
We found 12 studies in which any of the components of PF were compared between MHO and MAO. The most relevant information from each of these studies is presented in Table 1 . In addition, a summary of the characteristics of these studies is shown in Table 2 . Surprisingly, 75% of the studies focused exclusively on women 20-28 and only 25% focused on both women and men (no study was focused only in men) [29] [30] [31] .
Likewise, all studies 20-28,30,31 but one 29 were conducted in adults or older adults. These two observations inform us that the output and conclusion derived from this review would mainly apply to adult or older adult women.
Most of studies were conducted in Canada (n=6) 21,22,27-30 or in USA (n=2) 20,31 , with both comprising two thirds (50%+17%=67%) of the studies published on this topic. The concept of MHO, as indicated by its name, refers to obese individuals. However, 5 out of the 12 studies (42%) also included overweight participants and analyzed them together with the obese participants 21,25-27,29 , so that the results reported in these studies are referring to metabolically healthy but overweight or obese individuals. The definition of MHO differed across studies and could be summarized into 2 groups: 1) those based on meeting 0 or 1 (including or excluding waist circumference) of the metabolic syndrome criteria internationally accepted (yet with slight modifications in some studies) 32 , which was used in 75% of the studies [22] [23] [24] [25] [26] 28, 30, 31 ; and/or 2) markers of insulin sensitivity (mainly using top/bottom tertiles/quartiles of the hyperinsulinemiceuglycemic clamp), which was used in 33% of the studies 20,21,27,28 . 33 . This information has been included in Table 1 , so that the exact numbers are reported, and has also been graphically illustrated in Figure 1 . Figure   1 ) 20,21,23,25,27-31 . In our opinion, this small-to-moderate effect size is a reasonable and expected estimate, since other environmental factors as well as genetic factors additionally contribute to explain the variance in the metabolic profile of obese 8, [12] [13] [14] . In our previous study 31 , we observed that the differences in CRF between MHO and MAO were consistent and highly significant when obesity was defined according to BMI (N=5649 obese women and men) or body fat percentage -BF%-(N=12859 obese women and men) (Figure 2) . It is important to highlight that the mean CRF levels represented in Figure 2 (and also the standardized mean differences shown in Table 1 and Figure 1 ) are adjusted for a complete set of potential confounders (see Figure 2 's legend), while most (with only one exception 25 ) of the mean differences (Cohen's d values) from the rest of studies presented in Table 1 and Figure 1 were not adjusted for any potential confounder 21, 22, 24, [26] [27] [28] [29] [30] 35 or just for age 23 . In summary, these findings support the notion that a higher CRF should be considered as one more trait of the MHO phenotype. This conclusion is supported by recent data from intervention studies, in which Dalleck et al. 36 implemented a community-based exercise intervention program and observed that those participants who improved their CRF levels had higher chances to transition from MAO to MHO. For the first time, this study provides causal evidence supporting that the healthier metabolic profile of MHO can be partially achieved from their improved CRF level. In this context, it is important to highlight that transitioning from MHO to MAO is more likely to occur as age increases 5, 37 , future intervention studies should take into account that older people are at a higher risk of MAO.
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Differences in MS and other PF components between MHO and MAO
We found very little information about how other components of PF might differ between MHO and MAO. Two studies focused on MS and reported mixed findings.
Messier et al. 27 observed that when MS is expressed in relative terms (i.e. 
Does PF influence the prognosis of MHO? Current evidence from prospective longitudinal data
From a public health and clinical point of view, the most relevant question is related to the prognosis of MHO individuals when compared with MAO individuals and also when compared with normal-weight individuals. The present review identified only one study, conducted by our group, that explored the role of CRF (no study examining other PF components) in relation with the prognosis of MHO 31 . In that study, we observed
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10 that when models were not adjusted for CRF, the results suggested that obesity per se (either MHO or MAO) was associated with higher risk of all-cause, CVD and cancer mortality. However, the conclusion was modified when CRF was entered into the model, resulting in no difference in the prognosis between MHO and metabolically healthy normal-fat individuals. In addition, once CRF was accounted for and an accurate measure of adiposity was used, our results further supported that the MHO phenotype is a benign condition, with a better prognosis (30-50% lower risk) for mortality and morbidity than MAO individuals. The meta-analysis of Kramer et al. 9 concluded that there is no healthy pattern of increased weight, which is in agreement with our findings when CRF was not accounted for, but in disagreement with the CRFadjusted findings. A recent and large-cohort study provided evidence supporting that MHO is associated with a low risk for myocardial infarction, but obesity per se (with or without metabolic abnormalities) is associated with an increased risk of heart failure 39 ,
suggesting that different prognosis might exist for different manifestations of CVD. The authors acknowledged as a limitation the lack of CRF data in their study. Unfortunately, to the best of our knowledge (including information from systematically reviewes 9 ), no other previous study on this topic has considered the role of CRF in the prognosis of MHO individuals, which should be studied in the future. In summary, these findings suggest that CRF might play a key role in the prognosis of MHO individuals, yet these findings are based on a single study and need therefore to be confirmed or contrasted in future studies. Clearly, substantial data, including in the analysis of studies on the "obesity paradox" (at least in coronary heart disease and heart failure), point out that CRF markedly alters the relationship between measures of adiposity and subsequent prognosis [40] [41] [42] [43] [44] .
Nevertheless, although more emphasis should be placed on improving CRF 15 , obesity is still related with poorer mental health, social relationships, osteoarthritis and chronic pain, among others 45 . The public health message therefore is still to focus on prevention and treatment of obesity, but also against low levels of CRF 4 .
Proposal of a harmonized definition of the MHO and MAO phenotypes
While reviewing the existing literature on MHO individuals, it became clear that a harmonized definition of the MHO was highly needed. A standardized definition of MHO would increase the comparability of the data, allowing accurate meta-analyses in the future. Based on several facts, we hereby propose a harmonized definition of the MHO and MAO phenotypes ( Table 3) .
Future directions
In addition to the need of a harmonized MHO definition, several future directions for research have been identified in this review: 1) More investigation is needed for a better understanding of the interrelationship between MHO and cardiorespiratory fit obese phenotypes 46 ; 2) Whether the differences in PF between MHO and MAO differ by gender and whether the role of PF in the prognosis of MHO differ by gender is unknown and need to be addressed; 3) There is a need for further study on the role of PF, including both CRF and MS, in relation to the MHO phenotype (only 1 study found).
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Conclusions
The studies reviewed suggest that a higher CRF level should be considered a characteristic of the MHO phenotype. Likewise, CRF seems to play a key role in the prognosis of the MHO individuals, yet this statement is based on a single study and future studies are needed to confirm or contrast these findings. In a perfect world, all individuals would be fit and metabolically healthy at any weight. MHO group performed significantly better than MAO in CRF, static balance and dynamic balance/agility tests. There were not significant differences between groups in MS and flexibility tests. 48 for use in youth, which are based on sex-and-age specific cut-points interpolated from the adults' criteria (with the additional inclusion of hepatic triglyceride content); MAO otherwise. A C C E P T E D M A N U S C R I P T 32 , which is a consensus from major International Organizations, i.e. the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity .
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Recommendation 1:
To link the harmonized definition of MHO in adults to this consensus effort already done for metabolic syndrome.
Fact 2:
As indicated by its name, MHO individuals are already obese and consequently most of them meet the metabolic syndrome criterion of high waist circumference 23, 31 , specifically 80 to 95% of them, depending on the cut-points used (102/88cm versus 94/80cm 32 ).
Recommendation 2:
In accordance previous literature 8, 23, 25, 30, 31, 49 , we suggest to exclude waist circumference among the criteria to be considered for MHO.
Definition of MHO in adults
Based on the two facts and recommendations indicated above, a person would be classified as MHO if meeting 0 or 1* of the remaining metabolic syndrome criteria (i.e. after excluding waist circumference), which would be the following 
